FDA Advisory Board Endorses Pfizer’s Coronavirus Vaccine

Documents created by Pfizer for the meeting with the Food and Drug Administration advisory panel, as Pfizer seeks approval for emergency use of their COVID-19 vaccine, are seen on Thursday, Dec. 10, 2020. The meeting... Documents created by Pfizer for the meeting with the Food and Drug Administration advisory panel, as Pfizer seeks approval for emergency use of their COVID-19 vaccine, are seen on Thursday, Dec. 10, 2020. The meeting of outside advisers to the Food and Drug Administration represented the next-to-last hurdle before the expected start of the biggest vaccination campaign in U.S. history. Depending on how fast the FDA signs off on the panel's recommendation, shots could begin within days. (AP Photo/Jon Elswick) MORE LESS
Start your day with TPM.
Sign up for the Morning Memo newsletter

WASHINGTON (AP) — A U.S. government advisory panel has endorsed Pfizer’s coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak.

The Food and Drug Administration is expected to follow the recommendation issued Thursday by its expert advisers. The advisory group, in 17-4 vote with one abstention, concluded that the shot appears safe and effective against the coronavirus in people 16 and older.

A final FDA decision is expected within days. Millions of shots would then ship to begin vaccinating health care workers and nursing home residents. Widespread access to the general public is not expected until the spring.

Latest News

Notable Replies

  1. This is good news. Apparently next week Canada is getting this vaccine as well. My hope is that people don’t see it as the panacea. It’s the beginning. Everyone should be prepared to maintain safe distancing and masks for another 8 to 12 months.

  2. Did anyone seriously think they wouldn’t?

  3. This ^^^ and a vaccine is required at a minimum until enough have been vaccinated and the vaccine is shown to actually halt production of the virus. If the vaccine doesn’t halt production of the virus, then we might have to wait even longer while even more people get vaccinated.

  4. Avatar for jinnj jinnj says:

    NO … not seriously … and … was not surprised by some disagreement regarding labeling - specifically the lower end of the age cut in the indications for use .

    Several members of the committee expressed serious concerns about including 16- and 17-year-olds in the EUA, saying Pfizer has very little data on the vaccine’s safety in this group.

  5. For-ward MARCH!!!

Continue the discussion at forums.talkingpointsmemo.com

5 more replies

Participants

Avatar for discobot Avatar for srfromgr Avatar for drriddle Avatar for tao Avatar for jinnj Avatar for yellowbeard Avatar for garrybee Avatar for rucleare Avatar for Volvo_Birkenstock

Continue Discussion
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: